US Stock MarketDetailed Quotes
PDLI PDL BioPharma
- 0.000
- 0.0000.00%
Trading Nov 27 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)114.23MShares2.84052wk High0.00P/B0Float Cap2.39052wk Low--Dividend TTM79.15MShs Float21.801Historical High--Div YieldTTM0.00%Amplitude0.863Historical Low--Avg Price1Lot Size
PDL BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | (FY)Dec 31, 2018 | (Q4)Dec 31, 2018 | (Q3)Sep 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -316.42%-18.52M | -562.35%-15.25M | -331.81%-27.68M | -390.56%-14.38M | -332.85%-19.55M | 237.23%8.56M | 82.97%-2.3M | -115.78%-6.41M | 128.38%4.95M | 336.60%8.4M |
| Net income from continuing operations | 94.75%-421K | -275.85%-31.77M | -2.66%-70.69M | -436.80%-54.83M | -97.64%603K | 92.86%-8.01M | -627.59%-8.45M | -162.20%-68.86M | -27.12%16.28M | 23.27%25.56M |
| Operating gains losses | -37,950.00%-13.7M | 44,424.24%14.69M | 783.99%5M | 27,846.91%22.64M | -43,985.00%-17.63M | -157.14%-36K | 103.95%33K | -1,138.98%-731K | 305.00%81K | -126.67%-40K |
| Depreciation and amortization | -28.91%878K | -23.27%996K | 6.01%4.71M | 76.76%-2.99M | 98.05%5.17M | -83.33%1.24M | -82.21%1.3M | -82.00%4.44M | -305.92%-12.87M | -58.40%2.61M |
| Deferred tax | -100.29%-29K | 78.57%-129K | -197.46%-11.3M | -153.96%-8.03M | -257.99%-12.63M | 182.48%9.96M | -175.82%-602K | -70.39%11.6M | 45.87%14.88M | 3,258.50%7.99M |
| Other non cash items | -89.25%210K | -83.72%313K | -52.58%20.91M | -91.50%10.78M | 115.62%6.26M | 105.88%1.95M | 120.12%1.92M | 129.41%44.1M | 532.07%126.91M | -23.74%-40.05M |
| Change In working capital | -512.13%-5.64M | -821.20%-17.18M | 164.11%6.09M | 36.30%5.83M | -135.71%-3.49M | 114.14%1.37M | 117.16%2.38M | -142.67%-9.5M | 119.77%4.28M | 90.47%9.78M |
| -Change in receivables | 136.51%1.83M | -184.58%-1.25M | -820.51%-1.69M | 31.31%-10.5M | 211.56%12.35M | -263.16%-5M | -82.67%1.47M | -98.13%234K | -11.93%-15.29M | 138.93%3.96M |
| -Change in inventory | -497.43%-2.09M | -394.92%-3.9M | -433.63%-4.74M | -175.79%-1.96M | -169.78%-1.65M | 61.75%-350K | 83.98%-788K | -199.66%-889K | -18.73%2.58M | 611.47%2.36M |
| -Change in prepaid assets | -259.40%-7.28M | -1,499.43%-14.67M | 269.67%2.76M | -115.40%-451K | -206.20%-2.4M | 162.14%4.57M | 96.99%1.05M | 82.10%-1.63M | 159.34%2.93M | 254.09%2.26M |
| -Change in payables and accrued expense | 9.20%1.89M | 358.61%2.32M | 207.42%4.95M | -8.34%14.79M | -1,519.76%-12.07M | 135.08%1.73M | 103.03%505K | -122.37%-4.61M | 835.75%16.14M | -85.82%850K |
| -Change in other current assets | -71.24%67K | --0 | 92.30%-165K | -55.19%-523K | 82.48%-48K | 23.28%233K | 110.06%173K | ---2.14M | ---337K | ---274K |
| -Change in other current liabilities | -125.64%-50K | 1,228.57%316K | 1,175.11%4.97M | 356.83%4.47M | -46.91%326K | -24.71%195K | -106.88%-28K | ---462K | ---1.74M | --614K |
| Cash from discontinued investing activities | 125.67%5.45M | -155.22%-3.77M | 32.07%-4.77M | -21.25M | 6.82M | -7.02M | ||||
| Operating cash flow | -2.95%-13.06M | -521.24%-19.02M | -141.67%-32.44M | -826.67%-19.15M | -161.02%-5.12M | -103.53%-12.69M | 133.39%4.52M | -133.05%-13.43M | 88.15%-2.07M | 336.60%8.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 92.20%-142K | -121.43%-93K | 1.20%2.54M | 104.27%1.45M | 276.59%2.95M | -110.80%-1.82M | -100.20%-42K | -99.45%2.51M | -197.69%-34.02M | -100.66%-1.67M |
| Net PPE purchase and sale | -17.36%-142K | -121.43%-93K | 31.69%-763K | -107.35%-259K | 53.03%-341K | 95.19%-121K | 97.00%-42K | 13.88%-1.12M | 2,672.26%3.52M | -59.56%-726K |
| Net intangibles purchase and sale | ---- | ---- | 801.64%3.3M | -58.90%-58.29M | 6,804.45%63.29M | ---- | ---- | -99.83%366K | -211.67%-36.68M | -103.58%-944K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net investment purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -95.88%4.12M | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.59%-858K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 126.98%11.26M | 7.14%13.48M | -61.54%21.81M | 2.70%20.72M | 1,909.76%30.22M | -347.51%-41.72M | -41.06%12.58M | -87.64%56.7M | -42.05%20.18M | -100.66%-1.67M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 27.03%-19.69M | 10.20%-40.73M | -8.30%-190.44M | -319.57%-102.33M | -1,029.66%-15.77M | -34.59%-26.98M | 65.11%-45.36M | -47.27%-175.84M | -12,033.83%-24.39M | 98.40%-1.4M |
| Net issuance payments of debt | --0 | ---18.85M | 16.69%-105.34M | ---97.89M | ---7.45M | --0 | --0 | ---126.45M | --0 | --0 |
| Net common stock issuance | 25.32%-20.15M | 56.59%-19.23M | -76.95%-86.9M | 54.34%-11.01M | -231.30%-4.63M | -34.59%-26.98M | -1,144.04%-44.29M | -63.70%-49.11M | ---24.11M | ---1.4M |
| Cash dividends paid | ---- | ---- | 81.25%-9K | ---- | ---- | ---- | ---- | 78.38%-48K | ---- | ---- |
| Proceeds from stock option exercised by employees | --461K | ---3.46M | 38.36%-143K | ---- | ---- | --0 | --0 | ---232K | ---- | ---- |
| Net other financing activities | --0 | 174.79%801K | --1.95M | --6.72M | ---3.69M | --0 | ---1.07M | ---- | ---- | ---- |
| Cash from discontinued financing activities | 0 | -359K | 42.02%-69K | 0 | 0 | -119K | ||||
| Financing cash flow | 27.03%-19.69M | 9.41%-41.09M | -8.27%-190.51M | -317.81%-102.4M | -1,029.66%-15.77M | -34.59%-26.98M | 65.11%-45.36M | -47.37%-175.96M | -12,093.03%-24.51M | 98.40%-1.4M |
| Net cash flow | ||||||||||
| Beginning cash position | -63.29%125.51M | -50.97%193.45M | -25.16%394.59M | -26.61%294.27M | -35.17%256.49M | -15.61%341.86M | -25.16%394.59M | 258.31%527.27M | -21.39%400.98M | 13.23%395.65M |
| Current changes in cash | 73.59%-21.5M | -64.98%-46.63M | -51.60%-201.14M | -1,476.78%-100.82M | 75.00%9.33M | -763.48%-81.38M | 76.87%-28.27M | -134.90%-132.68M | -137.22%-6.39M | -96.68%5.33M |
| End cash Position | -58.89%105.45M | -63.29%125.51M | -53.79%168.98M | -53.79%168.98M | -26.61%294.27M | -35.17%256.49M | -15.61%341.86M | -30.65%365.68M | -30.65%365.68M | -21.39%400.98M |
| Free cash flow | 8.99%-13.21M | -527.27%-19.11M | -140.04%-34.91M | -190.43%-19.4M | 55.67%-5.47M | -65.80%-14.51M | 129.98%4.47M | -136.98%-14.54M | 222.09%21.46M | -207.92%-12.33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data